期刊文献+

益生菌制剂对结直肠癌患者围手术期的影响 被引量:7

Effects of perioperative probiotics administration on patients with colorectal cancer
原文传递
导出
摘要 目的探讨酪酸梭菌二联活菌对结直肠癌患者围手术期的影响及其作用机制。方法我院2011年5月至7月共70例限期行结直肠癌手术患者,采用随机数字表法分为试验组(n=35)和对照组(n=35)。两组于术前5d至术后7d每日分别给予酪酸梭菌二联活菌制剂和安慰剂,于术中采集结直肠组织标本,超微电镜下观察肠上皮紧密连接结构,采用Westernblot和实时RT—PCR技术分析肠黏膜上皮细胞紧密连接蛋白的表达,采用UssingChamber技术评估肠上皮通透性。术后第7天收集患者粪便标本和血标本,采用末端限制性片段长度多态性(T—RFLP)技术分析粪便菌群多样性,并采用细菌培养方法对特定细菌进行定量检测。记录患者术后首次排气排便时间、腹泻腹胀发生率、全身炎症反应及术后感染并发症等临床参数。结果与对照组比较,试验组的结直肠黏膜上皮紧密连接超微结构明显改善,Western blot和RT—PCR均证实试验组的紧密连接蛋白occludin、claudin-1和ZO-1的蛋白和mRNA表达水平显著提高(蛋白:P均〈0.001;mRNA:P=0.005、0.001、0.006),跨膜电阻增加[(28.3±5.2)Ω·cm2比(22.1±4.7)Ω·cm2,P=0.002],对大分子物质甘露醇的通透性降低[(0.91±0.17)%比(1.65±0.33)%,P〈0.001];肠道菌群的T—RFLP及细菌培养检测发现,试验组肠道菌群多样性增加(P=0.006),肠道双歧杆菌[(143.4±35.9)比(100.0±0.0),P=0.002]和乳酸杆菌[(111.3±52.9))比(100.0±0.0),P〈0.001]生长增加,产气荚膜梭菌生长减少[(66.2±23.7)比(100.0±0.0),P〈0.001]。临床观察发现,试验组术后排气[(2.5±1.7)d比(4.5±2.0)d,P〈0.001]和排便时间[(5.0±1.3)d比(6.3±1.1)d,P=0.002]显著缩短,腹泻(20%比40%,P=0.005)和腹胀发生率降低(35%比60%,P=0.021)。结论酪酸梭菌二联活菌用于结直肠癌患者围手术期可有效增强肠黏膜上皮屏障功能,维护肠道菌群稳态,显著缩短结直肠癌患者术后首次排气、排便时间,降低腹泻和腹胀发生率,促进肠功能恢复。 Objective To evaluate the effects of perioperative probiotics administration on patients with colorectal cancer and to explore its possible mechanism. Methods Seventy patients with colorectal cancer who were scheduled to undergo radical colorectomy at Shanghai Sixth People's Hospital between May 2011 and July 2011 were randomly divided with random number table into the control group (n = 35 ) and the treatment group ( n = 35 ). The two groups in 5 days preoperatively and 7 days postoperatively were given daily doses of probiotics preparation consisting of two combined live bacteria and placebo, respectively. The structure of intestinal epithelial tight junction was observed by electron microscopy in colorectal tissue specimens collected during the operation. The expression of tight junctional protein was detected using Western blot and real-time RT-PCR technology. Intestinal epithelial permeability was evaluated by Ussing Chamber system. Stool samples and blood samples were collected on the 7th day after operation. The diversity of faecal flora was analyzed by terminal restriction fragment length polymorphism (T-RFLP) technique, and the quantitative detection of specific bacteria was conducted by bacterial culture. Clinical parameters including the first exhaust and defecate time, distension and diarrhea incidence, systemic inflammatory response, and postoperative infective complications were recorded. Results Compared with the control group, the treatment group showed better intestinal epithelial tight junction ultrastructure. The expression of tight junction proteins occludin, claudin- 1, and ZO- 1 (protein : all P 〈 0. 001 ; mRNA : P = 0. 005, 0. 001, 0. 006) and the transepithelial electrical resistance [ (28.3 ± 5.2) Ω· cm2 vs. ( 22. 1 ± 4. 7) Ω· cm2, P = 0. 002 ] were significantly increased, the large molecule permeability [ (0. 91 ± 0. 17 ) % vs. ( 1.65 ± 0. 33 ) %, P 〈 0. 001 ] reduced, the diversity of intestinal flora (P = 0. 006) increased, the growth of intestinal Bifidobacteria [ ( 143.4 ± 35.9) vs. ( 100. 0 ± 0. 0), P = 0. 002 ] and Lactobacilli [ ( 111.3 ± 52. 9) vs. ( 100. 0 ± 0. 0), P 〈 0. 001 ] promoted, and the growth of Clostridium perfringens [ (66. 2 ±23.7) vs. ( 100. 0 ±0. 0), P 〈0. 001 ] inhibited in the treatment group. The treatment group also showed shorter postoperative exhaust [ (2.5 ± 1.7) d vs. (4. 5 ±2. 0) d, P 〈0. 001 ] and defecate time [ (5.0±1.3) dvs. (6.3±1.1) d, P=0.002], lower incidence of diarrhea (20% vs. 40%, P=0. 005) and abdominal distension (35 % vs. 60% , P=0. 021). Conclusion Probiotics used perioperatively in patients with colorectal cancer can effectively enhance the intestinal epithelia barrier function, maintain the homeostasis of gut flora, shorten the postoperative first exhaust and defecate time, reduce the incidence of diarrhea and abdominal distension, and promote the recovery of intestinal function.
出处 《中华临床营养杂志》 CAS CSCD 2014年第2期74-81,共8页 Chinese Journal of Clinical Nutrition
基金 基金项目:国家自然科学基金(81200264)
关键词 益生菌制剂 结直肠癌 围手术期 肠屏障功能 肠道菌群 Probiotics Colorectal cancer Perioperative period Intestinal barrier Intestinal flora
  • 相关文献

参考文献22

  • 1Frick JS, Autenrieth IB. The gut microflora and its variety of roles in health and disease [ J ]. Curr Top Microbiol Immunol, 2013, 358: 273-289.
  • 2Bengmark S. Pro- and synbiotics to prevent sepsis in major sur- gery and severe emergencies [J]. Nutrients, 2012, 4 (2) : 91-111.
  • 3Shimizu K, Ogura H, Asahara T, et al. Probiotic/synbiotic thera- py for treating critically ill patients from a gut microbiota perspec- tive [J]. Dig Dis Sci, 2013, 58 (1): 23-32.
  • 4Raman M, Ambalam P, Kondepudi KK, et al. Potential of pro- bioties, prebiotics and synbiotics for management of coloreetal cancer [J]. Gut Microbes, 2013, 4 (3): 181-192.
  • 5Laharie D, M6nard S, Aseneio C, et al. Effect of rebamipide on the colonic barrier in interleukin-10-deficient mice [ J]. Dig Dis Sci, 2007, 52 (1): 84-92.
  • 6Pitsouni E, Alexiou V, Saridakis V, et al. Does the use of probi- otics/synbioties prevent postoperative infections in patients under- going abdominal surgery? A recta-analysis of randomized con- trolled trials [J]. Enr J Clin Pharmaeol, 2009, 65 (6) : 561- 570.
  • 7Correia MI, Liboredo JC, Consoli ML. The role of probioties in gas- trointestinal surgery [J]. Nutrition, 2012, 28 (3) : 230-234.
  • 8Eguchi S, Takatsuki M, Hidaka Yi, et al. Perioperative synbiotic treatment to prevent infectious complications in patients after e- lective living donor liver transplantation: a prospective random-ized study [J]. Am J Surg, 2011, 201 (4) : 498-502.
  • 9Usami M, Miyoshi M, Kanbara Y, et al. Effects of perioperative synbiotic treatment on infectious complications, intestinal integri- ty, and fecal flora and organic acids in hepatic surgery with or without cirrhosis [ J]. JPEN J Parenter Enteral Nutr, 2011, 35 (3) : 317-328.
  • 10Kinross JM, Markar S, Karthikesalingam A, et al. A meta-analy- sis of probiotic and synbiotic use in elective surgery : does nutri- tion modulation of the gut microbiome improve clinical outcome.'? [ J]. JPEN J Parenter Enteral Nutr, 2013, 37 (2) : 243-253.

同被引文献56

  • 1吴承堂,谭建美.大肠癌术后肠道菌群变化的临床研究[J].中华普通外科杂志,2004,19(6):334-336. 被引量:36
  • 2林玉莲,蒋学华,杨俊毅,周静,张铃敏,山本昌.Labrasol对肠P-糖蛋白功能的影响[J].华西药学杂志,2005,20(2):139-142. 被引量:5
  • 3陈曦,孙炳伟.表皮生长因子(EGF)与肠道黏膜损伤的修复[J].江苏大学学报(医学版),2006,16(2):177-180. 被引量:5
  • 4杨振,秦环龙.Ussing chamber在肠道屏障功能研究中的进展[J].肠外与肠内营养,2006,13(4):233-236. 被引量:10
  • 5王克俭,曹玉根.益生菌肠内营养制剂在胃癌术后患者应用的临床研究[J].实用医技杂志,2007,14(29):3977-3979. 被引量:6
  • 6Klarin B, Johansson ML, Molin G, et al. Adhesion of the probiotic bacterium Lactobacillus plantarum 299v onto the gut mucosa in critically ill patients:a randomised open trial. Crit Care, 2005,9 (3) : R285.
  • 7Liu Z, Qin H, Yang Z, et al. Zheng. Randomised clinical trial : the effects of perioperative probiotic treatment on barrier function and post-operative infectious complications in colorectal cancer surger-y-a double-blind study. Alimentary Pharmacology and Therapeu- tics,2011,33 ( 1 ) :50-63.
  • 8Liu ZH, Huang M J, Zhang XW, et al. The effects of perioperative probiotic treatment on serum zonulin concentration and subse- quent postoperative infectious complications after colorectal canc- er surgery: a double-center and double-blind randomized clinical trial. Am J Clin Nutr,2013,97( 1 ) :117-1126.
  • 9Meddings JB,Swain MG. Environmental stress-induced gastroin- testinal permeability is mediated by endogenous glucocorticoids in the rat. Gastroenterology,2000,119 (4) : 1019.
  • 10Shimizu K, Ogura H, Asahara T, et al. Gastrointestinal dysmotility is associated with altered gut flora and septic mortality in patients with severe systemic inflammatory response syndrome:a prelimi- nary study. Neurogastroenterol Moti1,2011,23 (4) :330-335.

引证文献7

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部